Sibutramine administration in polycystic ovary syndrome treatment
Olszanecka-Glinianowicz, M.; Zahorska-Markiewicz, B.; Jochemczyk-Banek, U.; BanaÅ›, M.Å‚; Zurakowski, A.
Ginekologia Polska 75(6): 470-474
2004
ISSN/ISBN: 0017-0011 PMID: 15524424 Document Number: 578461
Obesity is considered important factor contributing development of PCOS. Insulin resistance, low level of serum SHBG and activation of pituitary-adrenal axis plays a major role in pathogenesis and symptoms of PCOS. The achievement of weight loss is an important factor in treatment of PCOS, but difficulties with adherences to the dietary regiment discourage physicians to use this method. In our paper we would like to show the effectiveness of such treatment and pay attention to possibilities of drug facilities in dietary approach in treatment of PCOS coexisting with obesity.